{
    "root": "2fc3d8ae-3605-f8df-e063-6294a90ab12f",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Oxybutynin Chloride",
    "value": "20250307",
    "ingredients": [
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "ANHYDROUS LACTOSE",
            "code": "3SY5LH9PMK",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "OXYBUTYNIN CHLORIDE",
            "code": "L9F3D9RENQ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_7857"
        }
    ],
    "indications": {
        "text": "oxybutynin chloride indicated relief symptoms bladder instability associated voiding patients uninhibited neurogenic reflex neurogenic bladder ( i.e . , urgency , frequency , urinary leakage , urge incontinence , dysuria ) .",
        "doid_entities": [
            {
                "text": "neurogenic bladder (DOID:12143)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_12143"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "adults usual dose one 5-mg tablet two three times day . maximum recommended dose one 5-mg tablet four times day . lower starting dose 2.5 mg two three times day recommended frail elderly . pediatric patients 5 years age usual dose one 5-mg tablet two times day . maximum recommended dose one 5-mg tablet three times day .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "oxybutynin chloride tablets usp , 5 mg , light light blue , round biconvex tablets , debossed \u201c \u201d \u201c 44 \u201d , separated horizontal score one side plain side . tablets supplied follows : bottles 60 : ndc 43063-851-60 bottles 90 : ndc 43063-851-90 bottles 100 : ndc 43063-851-01 pharmacist : dispense tight , light-resistant container defined usp . store 20\u00b0c 25\u00b0c ( 68\u00b0f 77\u00b0f ) ; excursions permitted within 15\u00b0c 30\u00b0c ( 59\u00b0f 86\u00b0f ) [ usp controlled room temperature ] .",
    "adverseReactions": "oxybutynin chloride contraindicated patients urinary retention , gastric retention severe decreased gastrointestinal motility conditions , uncontrolled narrow-angle glaucoma patients risk conditions . oxybutynin chloride also contraindicated patients demonstrated hypersensitivity substance components product .",
    "indications_original": "Oxybutynin chloride is indicated for the relief of symptoms of bladder instability associated with voiding in patients with uninhibited neurogenic or reflex neurogenic bladder (i.e., urgency, frequency, urinary leakage, urge incontinence, dysuria).",
    "contraindications_original": "Adults\n                       The usual dose is one 5-mg tablet two to three times a day. The maximum recommended dose is one\u00a05-mg tablet four times a day. A lower starting dose of 2.5 mg two or three times a day is recommended\u00a0for the frail elderly.\n\n \n                  \n                     \n                     Pediatric patients over 5 years of age\n                       The usual dose is one 5-mg tablet two times a day. The maximum recommended dose is one 5-mg\u00a0tablet three times a day.",
    "warningsAndPrecautions_original": "Oxybutynin Chloride Tablets USP, 5 mg, are very light to light blue, round biconvex tablets, debossed with \u201cA\u201d and \u201c44\u201d, separated by a horizontal score on one side and plain on the other side. The tablets are supplied as follows:\n                  Bottles of 60: NDC 43063-851-60\n                  Bottles of 90: NDC 43063-851-90\n                  Bottles of 100: NDC 43063-851-01\n                  Pharmacist: Dispense in a tight, light-resistant container as defined in the USP.\n                  Store at 20\u00b0C to 25\u00b0C (68\u00b0F to 77\u00b0F); excursions permitted within 15\u00b0C to 30\u00b0C (59\u00b0F to 86\u00b0F) [see USP Controlled Room Temperature].",
    "adverseReactions_original": "Oxybutynin chloride is contraindicated in patients with urinary retention, gastric retention and other severe decreased gastrointestinal motility conditions, uncontrolled narrow-angle glaucoma and in patients who are at risk for these conditions.\n                  Oxybutynin chloride is also contraindicated in patients who have demonstrated hypersensitivity to the drug substance or other components of the product.",
    "drug": [
        {
            "name": "Oxybutynin Chloride",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_7857"
        }
    ]
}